Educational information, not medical advice — ask your doctor or midwife.
Track Jaborandi with reminders and record whether it helped, in the app.
Jaborandi is a leafy shrub native to northeastern Brazil, used for centuries by indigenous peoples of the Amazon and surrounding regions. Its most important active compound, pilocarpine, was isolated in the 1870s and went on to become one of the first plant-derived compounds adopted into mainstream medicine. Today, the leaves remain a primary commercial source for pharmaceutical pilocarpine production worldwide.
Pilocarpine and related alkaloids in jaborandi stimulate the parasympathetic nervous system — the branch of your nervous system responsible for rest, digestion, and secretion. This triggers glands throughout the body to produce more fluid, which is why it increases saliva, tears, and sweat. On the scalp, it may improve circulation and stimulate hair follicle activity.
Traditional use centers on leaf infusions (teas) and scalp rinses. Modern herbal preparations include tinctures and liquid extracts. Pharmaceutical-grade pilocarpine eye drops and oral tablets are the most extensively studied forms, though these are standardized drugs rather than whole-herb products. Topical jaborandi tonics for hair are widely available in Brazilian and international markets.
Indigenous Brazilians used jaborandi leaves as a sweat-inducing treatment for fevers long before European contact. In 1874, the alkaloid pilocarpine was isolated by scientists, and it quickly entered the European pharmacopeia. By the late 19th century, jaborandi-derived pilocarpine was being used by ophthalmologists for glaucoma — making it one of the earliest examples of an indigenous plant remedy being validated and adopted into modern medicine.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Jaborandi is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.